Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
Eman Hasan1, Samuel Olusi2, Adel Al-Awadhi3, Khalid Mokaddem1, Prem Sharma4, Sunila George21Rheumatic Disease Unit, Al-Amiri Hospital, Ministry of Health, Kuwait; 2Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait; 3Department of Medicine, Faculty of Medicine, Kuwait University...
Enregistré dans:
Auteurs principaux: | Hasan E, Olusi S, Al-Awadhi A, Mokaddem K, Sharma P, George S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7dd9ded1fade44c59ee08f16571fc738 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009) -
Rituximab therapy in Greek patients with rheumatoid arthritis
par: Haralampos M Moutsopoulos, et autres
Publié: (2008) -
Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020) -
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
par: Joseph M Tuscano, et autres
Publié: (2009) -
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
par: Re KA, et autres
Publié: (2012)